Trial Outcomes & Findings for Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics) (NCT NCT03931174)
NCT ID: NCT03931174
Last Updated: 2025-03-19
Results Overview
Provider-level measure of whether the provider delivered the target number of CM sessions (at least 10 sessions) to at least one patient based on based on electronic medical record review and data entered into a study-specific CM tracker tool for up to 25 charts per site (25 charts\*30 sites = 750 charts). Providers will report on patient encounters in the electronic medical record and the study-specific CM tracker tool, and for each encounter will report if CM was provided. Using patient level data, providers will be classified as 1 (delivered 10 or more sessions to at least 1 patient) or 0 (did not deliver 10 or more CM sessions to any patients). \*This measure was initially defined as a patient-level outcome. We altered the level at which CM Exposure was assessed because our initial approach excluded providers who were trained but never delivered CM. To follow intent-to-treat principles, we aggregate CM Exposure data at the provider-level in a manner that uses all available data.
COMPLETED
NA
780 participants
From baseline to 9 months post-baseline
2025-03-19
Participant Flow
Participant milestones
| Measure |
Addiction Technology Transfer Center (ATTC) Training
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Providers
STARTED
|
95
|
91
|
|
Providers
Midpoint of Active Implementation (4.5 Months Post Baseline)
|
62
|
63
|
|
Providers
Endpoint of Active Implementation (9 Months Post Baseline)
|
54
|
58
|
|
Providers
COMPLETED
|
54
|
58
|
|
Providers
NOT COMPLETED
|
41
|
33
|
|
Patients
STARTED
|
286
|
308
|
|
Patients
3-month Follow-up
|
225
|
240
|
|
Patients
6-month Follow-up
|
224
|
217
|
|
Patients
COMPLETED
|
224
|
217
|
|
Patients
NOT COMPLETED
|
62
|
91
|
Reasons for withdrawal
| Measure |
Addiction Technology Transfer Center (ATTC) Training
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Providers
Staff left organization
|
26
|
25
|
|
Providers
Staff on leave/no longer engaged in implementation initiative
|
11
|
4
|
|
Providers
Lost to Follow-up
|
4
|
4
|
|
Patients
Post-consent screening failure
|
1
|
1
|
|
Patients
Death
|
1
|
1
|
|
Patients
Lost to Follow-up
|
60
|
89
|
Baseline Characteristics
Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
Baseline characteristics by cohort
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=381 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=399 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
Total
n=780 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
Providers
|
40.92 Years
STANDARD_DEVIATION 12.56 • n=95 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
38.68 Years
STANDARD_DEVIATION 12.21 • n=91 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
39.83 Years
STANDARD_DEVIATION 12.40 • n=186 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Age, Customized
Patients
|
38.15 Years
STANDARD_DEVIATION 10.11 • n=286 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
37.48 Years
STANDARD_DEVIATION 10.28 • n=308 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
37.83 Years
STANDARD_DEVIATION 10.19 • n=594 Participants • Age was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Sex/Gender, Customized
Providers · Female
|
77 Participants
n=95 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
75 Participants
n=91 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
152 Participants
n=186 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Sex/Gender, Customized
Providers · Male
|
18 Participants
n=95 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
16 Participants
n=91 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
34 Participants
n=186 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Sex/Gender, Customized
Patients · Female
|
129 Participants
n=286 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
137 Participants
n=308 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
266 Participants
n=594 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Sex/Gender, Customized
Patients · Male
|
157 Participants
n=286 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
171 Participants
n=308 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
328 Participants
n=594 Participants • Sex/Gender was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · American Indian or Alaska Native
|
1 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
0 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
1 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · Asian
|
1 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
0 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
1 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · Native Hawaiian or Pacific Islander
|
0 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
0 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
0 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · Black or African American
|
6 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
7 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
13 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · White
|
74 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
73 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
147 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · More than one race
|
9 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
8 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
17 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Providers · Unknown or Not Reported
|
4 Participants
n=95 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
3 Participants
n=91 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
7 Participants
n=186 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · American Indian or Alaska Native
|
3 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
5 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
8 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · Asian
|
0 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
4 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
4 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · Native Hawaiian or Pacific Islander
|
2 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
1 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
3 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · Black or African American
|
20 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
22 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
42 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · White
|
212 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
233 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
445 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · More than one race
|
20 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
15 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
35 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Race/Ethnicity, Customized
Patients · Unknown or Not Reported
|
29 Participants
n=286 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
28 Participants
n=308 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
57 Participants
n=594 Participants • Race/Ethnicity was assessed by provider (95= ATTC, 91= E-ATTC) and patient (286= ATTC, 308= E-ATTC) groups.
|
|
Region of Enrollment
United States · Providers
|
95 Participants
n=381 Participants
|
91 Participants
n=399 Participants
|
186 Participants
n=780 Participants
|
|
Region of Enrollment
United States · Patients
|
286 Participants
n=381 Participants
|
308 Participants
n=399 Participants
|
594 Participants
n=780 Participants
|
|
CM Exposure
|
0 Participants
n=381 Participants
|
0 Participants
n=399 Participants
|
0 Participants
n=780 Participants
|
PRIMARY outcome
Timeframe: From baseline to 9 months post-baselinePopulation: Table reports proportions with listwise deletion. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from all 95 ATTC providers and 91 E-ATTC.
Provider-level measure of whether the provider delivered the target number of CM sessions (at least 10 sessions) to at least one patient based on based on electronic medical record review and data entered into a study-specific CM tracker tool for up to 25 charts per site (25 charts\*30 sites = 750 charts). Providers will report on patient encounters in the electronic medical record and the study-specific CM tracker tool, and for each encounter will report if CM was provided. Using patient level data, providers will be classified as 1 (delivered 10 or more sessions to at least 1 patient) or 0 (did not deliver 10 or more CM sessions to any patients). \*This measure was initially defined as a patient-level outcome. We altered the level at which CM Exposure was assessed because our initial approach excluded providers who were trained but never delivered CM. To follow intent-to-treat principles, we aggregate CM Exposure data at the provider-level in a manner that uses all available data.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=95 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=91 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
CM Exposure (Implementation Outcome)
|
18 Participants
|
31 Participants
|
PRIMARY outcome
Timeframe: From baseline to 9 months post-baselinePopulation: Table reports means and standard deviations. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from all 95 ATTC providers and 91 E-ATTC providers.
Provider scores on the Contingency Management Competence Scale for Reinforcing Attendance (CMCS; Petry \& Ledgerwood, 2010). Coders blind to treatment condition rate audio recorded CM sessions using the CMCS, which measures provider skill in CM delivery. CMCS contains 6 CM-specific skill items and 3 general skill items that are scored on a scale from 0 to 7. For each item, a score of 0 indicates an audio recording was not submitted, a score of 1 indicates the lowest possible skill and a score of 7 indicates the highest possible skill. Possible scale scores range from a minimum of 0 to 63. An average score will be calculated for each provider, with a minimum of 0 and maximum of 7. Providers will submit one audio recording per month for the duration of the 9-month Implementation phase. Each provider's highest CMCS score will be used in analysis. Higher scores indicate higher skill, which is a better outcome.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=95 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=91 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Contingency Management Competence Scale for Reinforcing Attendance (Implementation Outcome)
|
0.53 Units on the CM Competence Scale
Standard Deviation 1.66
|
1.25 Units on the CM Competence Scale
Standard Deviation 2.14
|
PRIMARY outcome
Timeframe: 6-month time interval following Implementation time periodPopulation: Sustainment was measured at the organizational level (N=14 ATTC, N=14 E-ATTC) as a dichotomous variable indicating whether or not they continued delivering the intervention. The number of participants seen in each condition is unknown and therefore overall number of participants is entered as NA (not applicable).
Proportion of programs delivering any CM after removal of active support. This is calculated based on review of all patient charts over a 6-month interval. Providers report on patient encounters in the medical record, and for each encounter report if CM was provided. Programs are classified as 1 (reported delivering CM to at least 1 patient) or 0 (did not deliver CM to any patients). The proportion of programs delivering CM is then calculated; a higher proportion is a better outcome. \*The level at which CM Sustainment was assessed was altered from provider-level to program-level because of the frequency of programs failing to report applying CM among any patients, across any of its providers. In addition, there was such high staff turnover we could not assess at the provider-level using original provider IDs. To be able to use all available data from all programs' medical records, we report on the proportion of any programs delivering CM after removal of active support.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=14 Organization Sites
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=14 Organization Sites
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
CM Sustainment (Implementation Outcome)
|
6 Organization Sites
|
6 Organization Sites
|
SECONDARY outcome
Timeframe: Assessed at 3 and 6-months from patient baseline assessmentPopulation: Table reports means and standard deviations with listwise deletion. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from all patients who reported any follow-up data (N = 592).
Days of abstinence as reported using calendar-based recall based on the Timeline Followback Interview method (Sobell \& Sobell, 1992). Days of opioid abstinence will be calculated from 0 to 30 for each patient, with higher numbers indicating more days of abstinence (which is a better outcome). This will be calculated for all patients who complete follow-up.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=286 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=308 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Opioid Abstinence: Past Month (Patient Outcome)
6-months post baseline
|
10.15 Days of opioid abstinence
Standard Deviation 16.33
|
8.33 Days of opioid abstinence
Standard Deviation 14.70
|
|
Opioid Abstinence: Past Month (Patient Outcome)
3-months post baseline
|
8.89 Days of opioid abstinence
Standard Deviation 13.12
|
9.39 Days of opioid abstinence
Standard Deviation 14.00
|
SECONDARY outcome
Timeframe: Assessed at 3 and 6-months from patient baseline assessmentPopulation: Table reports means and standard deviations with listwise deletion. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from all patients who reported any follow-up data (N = 592).
Count of problems as reported using an adapted version of the Global Appraisal of Needs Substance Problems Scale (Dennis et al., 2002), which has been adapted to focus specifically on problems related to opioids. The scale contains 16 items that correspond to problems related to opioid use. Patients are asked the last time they had each problem with responses including past month, past year, lifetime, or never. A count of problems experienced over the past month will be calculated for each patient. The minimum possible score is 0 and the maximum possible score is 16. Higher scores indicate higher problems, which is a worse outcome. This will be calculated for all patients who complete follow-up.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=286 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=308 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Global Appraisal of Individual Needs Opioid-Related Problem Scale: Past Month (Patient Outcome)
3-months post baseline
|
2.43 Units on a scale
Standard Deviation 3.51
|
2.55 Units on a scale
Standard Deviation 3.67
|
|
Global Appraisal of Individual Needs Opioid-Related Problem Scale: Past Month (Patient Outcome)
6-months post baseline
|
2.24 Units on a scale
Standard Deviation 3.47
|
2.17 Units on a scale
Standard Deviation 3.69
|
OTHER_PRE_SPECIFIED outcome
Timeframe: From baseline to 9 months post baselinePopulation: Table reports means and standard deviations with listwise deletion. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from N=54 ATTC providers and N=58 E-ATTC providers.
Implementation climate scale (Jacobs et al., 2014). This scale contains 6 items scored on a 1 to 5 scale. An average score across the 6 items will be calculated per provider. Possible scores on this outcome range from a minimum of 1 to a maximum of 6. Higher scores indicate a more positive implementation climate, which is a better outcome.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=54 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=58 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Implementation Climate Scale
|
3.77 Units on Implementation Climate Scale
Standard Deviation 1.17
|
4.27 Units on Implementation Climate Scale
Standard Deviation 0.81
|
OTHER_PRE_SPECIFIED outcome
Timeframe: From baseline to 9 months post baselinePopulation: Table reports means and standard deviations with listwise deletion. The pre-specified plan uses mixed models with full maximum likelihood estimation (intent-to-treat) and data from N=53 ATTC providers and N=58 E-ATTC providers.
Measure of leadership engagement (Garner, unpublished data). The scale contains 4 items scored on a 1 to 5 scale. An average perceived leadership engagement scale will be calculated for each provider. Possible scores on this outcome range from a minimum score of 1 to a maximum score of 5. Higher scores indicate higher perceived leadership engagement, which is a better outcome.
Outcome measures
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=53 Participants
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=58 Participants
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Leadership Engagement Scale
|
3.47 Units on Leadership Engagement Scale
Standard Deviation 1.27
|
3.75 Units on Leadership Engagement Scale
Standard Deviation 1.17
|
Adverse Events
Addiction Technology Transfer Center (ATTC) Training
Enhanced ATTC (E-ATTC) Training Strategy
Serious adverse events
| Measure |
Addiction Technology Transfer Center (ATTC) Training
n=381 participants at risk
Half of the opioid treatment centers will receive the ATTC training strategy.
Addiction Technology Transfer Center (ATTC) Training Strategy: Participating organizations will receive training consisting of 3 components: 1) didactic workshop - full-day workshop led by a contingency management (CM) expert for both CM staff and leaders, 2) performance feedback - submission of CM session recordings for review and performance feedback at least monthly for 9 months for CM staff, and 3) staff coaching - monthly provider coaching calls led by a CM expert for 9 months for both CM staff and leaders.
|
Enhanced ATTC (E-ATTC) Training Strategy
n=399 participants at risk
Half of the opioid treatment centers will receive the E-ATTC training strategy.
Enhanced Addiction Technology Transfer Center (E-ATTC) Training Strategy: Participating organizations will receive all of the elements of the ATTC control condition. In addition, organizations will receive two additional elements: 1) Implementation Sustainment Facilitation - monthly coaching calls for CM leaders and staff focused on sustainment, 2) Pay for Performance - participating CM staff will have the opportunity to earn monthly monetary bonuses for achieving pre-defined implementation goals for 9 months.
|
|---|---|---|
|
Injury, poisoning and procedural complications
Death
|
0.26%
1/381 • Number of events 1 • Adverse event data were collected as part of comprehensive follow-up assessments (twice over a 6-month period for patients and twice over a 9-month period for providers).
Used standard National Institutes of Health definition of study-related adverse and serious adverse events. Adverse events and serious adverse events were assessed systematically as part of the comprehensive follow-up assessments.
|
0.25%
1/399 • Number of events 1 • Adverse event data were collected as part of comprehensive follow-up assessments (twice over a 6-month period for patients and twice over a 9-month period for providers).
Used standard National Institutes of Health definition of study-related adverse and serious adverse events. Adverse events and serious adverse events were assessed systematically as part of the comprehensive follow-up assessments.
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place